angiotensin converting enzyme inhibitors (ACEIs)
DISEASE INTERVENTION COMPARISON RESULTS
Lancet. 2000 May 6;355(9215):1575-1581 Meta-Analysis
IN heart failure, chronic, systolic The Use of
angiotensin converting enzyme inhibitors (ACEIs)
As Treatment, Chronic
Is better Than
placebo
To reduce at 3 years death (23% ACEI VS 27% placebo), reinfarction or rehospitalisation